Mehrdad Arjomandi, MD
Professor
Medicine
School of Medicine

When in California, he began his higher education at Los Angeles Pierce College before transferring to University of California San Diego in 1988, where he obtained a bachelor degree in molecular biology and completed a senior honors thesis in developmental biology in Dr. Richard Firtel’s lab. He then attended Stanford University School of Medicine in 1991, completing two predoctoral research fellowships in Dr. Etienne Emile Beaulieu’s lab at INSERM in Paris, France, and Dr. John Cooke’s vascular biology lab at Stanford. Dr. Arjomandi then completed a residency in internal medicine at UCLA (1996-99) and a fellowship in pulmonary and critical care at UCSF (2000-03). He completed three additional years of research fellowship funded by the American Lung Association and Chest Foundation before successfully competing for an NIH K23 award in 2006 and then joining the pulmonary and critical care faculty at UCSF and San Francisco General Hospital (SFGH). In 2008, he obtained a joint appointment at San Francisco VA Medical Center (SF VA).

Currently, Dr. Arjomandi is Professor of Medicine in the Divisions of Pulmonary, Critical Care, Allergy, and Sleep Medicine and Occupational and Environmental Medicine at UCSF with a joint appointment at SF VA. He is Director of the UCSF Human Exposure Laboratory at SFGH, Director of Environmental Medicine Clinic at SF VA, Site Director for the SF VA Airborne Hazard Exposure Study Center of Excellence, an investigator at the UCSF Center for Tobacco Control Research and Education, and a member of the UCSF Helen Diller Family Comprehensive Cancer Center.

Research Interests

The lung is constantly exposed to various environmental pollutants, allergens, and toxins, which interact with airways and alveoli and result in inflammation, injury, and disease. My laboratory primary research interest has been centered on the paradigm that respiratory exposures to pollutants and toxicants contribute to development and progression of chronic lung diseases, and may further yield systemic effects well beyond lungs. Under this paradigm, my research activities have focused on understanding the physiologic and immunologic mechanisms via which environmental exposures contribute to chronic lung diseases and how knowledge of these mechanisms could be translated to ways to better define, prognosticate, and manage disease burden at both individual and societal levels.

I have dedicated my efforts to (1) investigate the biology of airway immune cells using inhalational exposure to ozone in humans as a model of lung injury simulating exacerbation in chronic lung disease, and (2) characterize the early cardiopulmonary changes due to exposure to tobacco smoke and the pathophysiology and biology associated with those changes.

• The Effect of Chronic Altitude Exposure on COPD Outcomes in the SPIROMICS Cohort.
  American journal of respiratory and critical care medicine 2024 Suri R, Markovic D, Woo H, Arjomandi M, Barr RG, Bowler RP, Criner G, Curtis JL, Dransfield MT, Drummond MB, Fortis S, Han MK, Hoffman EA, Kaner RJ, Kaufman JD, Krishnan JA, Martinez FJ, Ohar J, …
• Effect of twice daily inhaled albuterol on cardiopulmonary exercise outcomes, dynamic hyperinflation, and symptoms in secondhand tobacco-exposed persons with preserved spirometry and air trapping: a randomized controlled trial.
  BMC pulmonary medicine 2024 Zeng S, Nishihama M, Weldemichael L, Lozier H, Gold WM, Arjomandi M
• Response.
  Chest 2024 Seedahmed MI, Albirair MT, Whooley MA, Koth LL, Blanc PD, Arjomandi M
• Effect of a single one-hour teaching session about environmental pollutants and climate change on the understanding and behavioral choices of adolescents: The BREATHE pilot randomized controlled trial.
  PloS one 2023 Abrham Y, Zeng S, Tenney R, Davidson C, Yao E, Kloth C, Dalton S, Arjomandi M
• Lung volumes differentiate the predominance of emphysema versus airway disease phenotype in early COPD: an observational study of the COPDGene cohort.
  ERJ open research 2023 Zeng S, Luo G, Lynch DA, Bowler RP, Arjomandi M
• Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
  JAMA 2023 McKleroy W, Shing T, Anderson WH, Arjomandi M, Awan HA, Barjaktarevic I, Barr RG, Bleecker ER, Boscardin J, Bowler RP, Buhr RG, Criner GJ, Comellas AP, Curtis JL, Dransfield M, Doerschuk CM, Dolezal …
• Screening for Exposure to Beryllium Among US Veterans With a Diagnosis of Sarcoidosis, 2002-2020.
  Chest 2023 Seedahmed MI, Albirair MT, Whooley MA, Koth LL, Blanc PD, Arjomandi M
• Epidemiology of Sarcoidosis in U.S. Veterans from 2003 to 2019.
  Annals of the American Thoracic Society 2023 Seedahmed MI, Baugh AD, Albirair MT, Luo Y, Chen J, McCulloch CE, Whooley MA, Koth LL, Arjomandi M
• A MUC5B Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or Mortality.
  American journal of respiratory and critical care medicine 2022 Verma A, Minnier J, Wan ES, Huffman JE, Gao L, Joseph J, Ho YL, Wu WC, Cho K, Gorman BR, Rajeevan N, Pyarajan S, Garcon H, Meigs JB, Sun YV, Reaven PD, McGeary JE, Suzuki A, Gelernter J, Lynch JA, …
• Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
  Chest 2022 Fortis S, Quibrera PM, Comellas AP, Bhatt SP, Tashkin DP, Hoffman EA, Criner GJ, Han MK, Barr RG, Arjomandi M, Dransfield MB, Peters SP, Dolezal BA, Kim V, Putcha N, Rennard SI, Paine R, Kanner RE, …
• Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.
  The New England journal of medicine 2022 Han MK, Ye W, Wang D, White E, Arjomandi M, Barjaktarevic IZ, Brown SA, Buhr RG, Comellas AP, Cooper CB, Criner GJ, Dransfield MT, Drescher F, Folz RJ, Hansel NN, Kalhan R, Kaner RJ, Kanner RE, …
• Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study.
  American journal of respiratory and critical care medicine 2022 Buhr RG, Barjaktarevic IZ, Quibrera PM, Bateman LA, Bleecker ER, Couper DJ, Curtis JL, Dolezal BA, Han MK, Hansel NN, Krishnan JA, Martinez FJ, McKleroy W, Paine R, Rennard SI, Tashkin DP, Woodruff PG…
• Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease.
  American journal of respiratory and critical care medicine 2022 Madapoosi SS, Cruickshank-Quinn C, Opron K, Erb-Downward JR, Begley LA, Li G, Barjaktarevic I, Barr RG, Comellas AP, Couper DJ, Cooper CB, Freeman CM, Han MK, Kaner RJ, Labaki W, Martinez FJ, Ortega …
• Postdeployment Respiratory Health: The Roles of the Airborne Hazards and Open Burn Pit Registry and the Post-Deployment Cardiopulmonary Evaluation Network.
  Federal practitioner : for the health care professionals of the VA, DoD, and PHS 2022 Davis CW, Rabin AS, Jani N, Osterholzer JJ, Krefft S, Hines SE, Arjomandi M, Robertson MW, Sotolongo AM, Falvo MJ, Post-Deployment Cardiopulmonary Evaluation Network
• NF-κB inhibitor alpha has a cross-variant role during SARS-CoV-2 infection in ACE2-overexpressing human airway organoids.
  bioRxiv : the preprint server for biology 2022 Simoneau CR, Chen PY, Xing GK, Khalid MM, Meyers NL, Hayashi JM, Taha TY, Leon KE, Ashuach T, Fontaine KA, Rodriguez L, Joehnk B, Walcott K, Vasudevan S, Fang X, Maishan M, Schultz S, Roose J, Matthay…
• Association of Kidney Comorbidities and Acute Kidney Failure With Unfavorable Outcomes After COVID-19 in Individuals With the Sickle Cell Trait.
  JAMA internal medicine 2022 Verma A, Huffman JE, Gao L, Minnier J, Wu WC, Cho K, Ho YL, Gorman BR, Pyarajan S, Rajeevan N, Garcon H, Joseph J, McGeary JE, Suzuki A, Reaven PD, Wan ES, Lynch JA, Petersen JM, Meigs JB, Freiberg MS…
• Elastin Degradation and Lung Function Deterioration with Remote Secondhand Tobacco Smoke Exposure in Never-smokers.
  Chronic obstructive pulmonary diseases (Miami, Fla.) 2022 Mustra Rakic J, Zeng S, Rohdin-Bibby L, Van Blarigan EL, Liu X, Ma S, Kane JP, Redberg RF, Turino GM, Oestreicher Stock E, Arjomandi M
• Effect of ozone on allergic airway inflammation.
  The journal of allergy and clinical immunology. Global 2022 Arjomandi M, Wong H, Tenney R, Holland N, Balmes JR
• Remote exposure to secondhand tobacco smoke is associated with lower exercise capacity through effects on oxygen pulse, a proxy of cardiac stroke volume.
  BMJ open respiratory research 2022 Zeng S, Dunn M, Gold WM, Kizer JR, Arjomandi M
• Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort.
  Chronic obstructive pulmonary diseases (Miami, Fla.) 2022 Ronish BE, Couper DJ, Barjaktarevic IZ, Cooper CB, Kanner RE, Pirozzi CS, Kim V, Wells JM, Han MK, Woodruff PG, Ortega VE, Peters SP, Hoffman EA, Buhr RG, Dolezal BA, Tashkin DP, Liou TG, Bateman LA, …
• Performance of a Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: Case Validation Study From 2 Veterans Affairs Medical Centers.
  JMIR formative research 2022 Seedahmed MI, Mogilnicka I, Zeng S, Luo G, Whooley MA, McCulloch CE, Koth L, Arjomandi M
• Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study.
  JMIR medical informatics 2022 Zeng S, Arjomandi M, Luo G
• Genetic Loci Associated With COVID-19 Positivity and Hospitalization in White, Black, and Hispanic Veterans of the VA Million Veteran Program.
  Frontiers in genetics 2022 Peloso GM, Tcheandjieu C, McGeary JE, Posner DC, Ho YL, Zhou JJ, Hilliard AT, Joseph J, O'Donnell CJ, Efird JT, Crawford DC, Wu WC, Arjomandi M, VA Million Veteran Program COVID-19 Science Initiative,…
• Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study.
  Journal of medical Internet research 2022 Zeng S, Arjomandi M, Tong Y, Liao ZC, Luo G
• Effects of short-term increases in personal and ambient pollutant concentrations on pulmonary and cardiovascular function: A panel study analysis of the Multicenter Ozone Study in oldEr subjects (MOSES 2).
  Environmental research 2021 Frampton MW, Balmes JR, Bromberg PA, Arjomandi M, Hazucha MJ, Thurston SW, Alexis NE, Ganz P, Zareba W, Koutrakis P, Thevenet-Morrison K, Rich DQ
• Significance of FEV3/FEV6 in Recognition of Early Airway Disease in Smokers at Risk of Development of COPD: Analysis of the SPIROMICS Cohort.
  Chest 2021 Yee N, Markovic D, Buhr RG, Fortis S, Arjomandi M, Couper D, Anderson WH, Paine R, Woodruff PG, Han MK, Martinez FJ, Barr RG, Wells JM, Ortega VE, Hoffman EA, Kim V, Drummond MB, Bowler RP, Curtis JL,…
• Actigraphy informs distinct patient-centered outcomes in Pre-COPD.
  Respiratory medicine 2021 Chen J, Weldemichael L, Zeng S, Giang B, Geerts J, Ching WC, Nishihama M, Gold WM, Arjomandi M
• Lung immune tone via gut-lung axis: gut-derived LPS and short-chain fatty acids' immunometabolic regulation of lung IL-1β, FFAR2, and FFAR3 expression.
  American journal of physiology. Lung cellular and molecular physiology 2021 Liu Q, Tian X, Maruyama D, Arjomandi M, Prakash A
• Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.
  Chest 2021 Fortis S, Comellas AP, Bhatt SP, Hoffman EA, Han MK, Bhakta NR, Paine R, Ronish B, Kanner RE, Dransfield M, Hoesterey D, Buhr RG, Barr RG, Dolezal B, Ortega VE, Drummond MB, Arjomandi M, Kaner RJ, Kim…
• Lower PDL1, PDL2, and AXL Expression on Lung Myeloid Cells Suggests Inflammatory Bias in Smoking and Chronic Obstructive Pulmonary Disease.
  American journal of respiratory cell and molecular biology 2020 Vasudevan S, Vásquez JJ, Chen W, Aguilar-Rodriguez B, Niemi EC, Zeng S, Tamaki W, Nakamura MC, Arjomandi M
• Do Ambient Ozone or Other Pollutants Modify Effects of Controlled Ozone Exposure on Pulmonary Function?
  Annals of the American Thoracic Society 2020 Rich DQ, Thurston SW, Balmes JR, Bromberg PA, Arjomandi M, Hazucha MJ, Alexis NE, Ganz P, Zareba W, Thevenet-Morrison K, Koutrakis P, Frampton MW
• Multicenter Ozone Study in oldEr Subjects (MOSES): Part 2. Effects of Personal and Ambient Concentrations of Ozone and Other Pollutants on Cardiovascular and Pulmonary Function.
  Research report (Health Effects Institute) 2020 Rich DQ, Frampton MW, Balmes JR, Bromberg PA, Arjomandi M, Hazucha MJ, Thurston SW, Alexis NE, Ganz P, Zareba W, Koutrakis P, Thevenet-Morrison K
• Laboratory-based Intermountain Validated Exacerbation (LIVE) Score stability in patients with chronic obstructive pulmonary disease.
  BMJ open respiratory research 2020 Blagev DP, Collingridge DS, Rea S, Carey KA, Mularski RA, Zeng S, Arjomandi M, Press VG
• Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis.
  International journal of chronic obstructive pulmonary disease 2019 Barjaktarevic IZ, Buhr RG, Wang X, Hu S, Couper D, Anderson W, Kanner RE, Paine Iii R, Bhatt SP, Bhakta NR, Arjomandi M, Kaner RJ, Pirozzi CS, Curtis JL, O'Neal WK, Woodruff PG, Han MK, Martinez FJ, …
• Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
  The European respiratory journal 2019 Arjomandi M, Zeng S, Barjaktarevic I, Barr RG, Bleecker ER, Bowler RP, Buhr RG, Criner GJ, Comellas AP, Cooper CB, Couper DJ, Curtis JL, Dransfield MT, Han MK, Hansel NN, Hoffman EA, Kaner RJ, Kanner …
• Ozone effects on blood biomarkers of systemic inflammation, oxidative stress, endothelial function, and thrombosis: The Multicenter Ozone Study in oldEr Subjects (MOSES).
  PloS one 2019 Balmes JR, Arjomandi M, Bromberg PA, Costantini MG, Dagincourt N, Hazucha MJ, Hollenbeck-Pringle D, Rich DQ, Stark P, Frampton MW
• Back to the Box: Using Lung Volumes to Predict Susceptibility to Develop Chronic Obstructive Pulmonary Disease among Smokers.
  Annals of the American Thoracic Society 2018 Zeng S, Tham A, Bos B, Jin J, Arjomandi M
• Inflammatory Phenotypes Associated with Chronic Obstructive Pulmonary Disease Increase Susceptibility to Exacerbation. Lessons from Single Cell Analysis of Lung Macrophages.
  Annals of the American Thoracic Society 2018 Vasudevan S, Vasquez J, Chen W, Zeng S, Arjomandi M
• Analytical validation of a novel multi-analyte plasma test for lung nodule characterization.
  Biomedical research and reviews 2018 Trivedi NN, Brown JK, Rubenstein T, Rostykus AD, Fish AL, Yu H, Carbonell L, Juang A, Kamer S, Patel B, Sidhu M, Vuong D, Wang S, Beggs M, Wu AH, Arjomandi M
• Risk assessment for indeterminate pulmonary nodules using a novel, plasma-protein based biomarker assay.
  Biomedical research and clinical practice 2018 Trivedi NN, Arjomandi M, Brown JK, Rubenstein T, Rostykus AD, Esposito S, Axler E, Beggs M, Yu H, Carbonell L, Juang A, Kamer S, Patel B, Wang S, Fish AL, Haddad Z, Wu AH
• MA23.03 Risk Assessment for Indeterminate Pulmonary Nodules Using a Novel, Plasma-Protein Based Biomarker Assay.
  Journal of Thoracic Oncology 2018 A. Fish, A. Vachani, M. Beggs, L. Carbonell, Z. Haddad, A. Juang, S. Kamer, B. Patel, H. Yu, A. Wu, P. Massion, M. Arjomandi, J. Brown, N. Trivedi, T. Rubenstein
• E-cigarettes versus nicotine patches for perioperative smoking cessation: a pilot randomized trial.
  PeerJ 2018 Lee SM, Tenney R, Wallace AW, Arjomandi M
• Lung volume indices predict morbidity in smokers with preserved spirometry.
  Thorax 2018 Zeng S, Tham A, Bos B, Jin J, Giang B, Arjomandi M
• Cardiovascular function and ozone exposure: The Multicenter Ozone Study in oldEr Subjects (MOSES).
  Environment international 2018 Rich DQ, Balmes JR, Frampton MW, Zareba W, Stark P, Arjomandi M, Hazucha MJ, Costantini MG, Ganz P, Hollenbeck-Pringle D, Dagincourt N, Bromberg PA
• Marijuana Use, Respiratory Symptoms, and Pulmonary Function: A Systematic Review and Meta-analysis.
  Annals of internal medicine 2018 Ghasemiesfe M, Ravi D, Vali M, Korenstein D, Arjomandi M, Frank J, Austin PC, Keyhani S
• Stability of Frequency of Severe Chronic Obstructive Pulmonary Disease Exacerbations and Health Care Utilization in Clinical Populations.
  Chronic obstructive pulmonary diseases (Miami, Fla.) 2018 Blagev DP, Collingridge DS, Rea S, Press VG, Churpek MM, Carey K, Mularski RA, Zeng S, Arjomandi M
• The Laboratory-Based Intermountain Validated Exacerbation (LIVE) Score Identifies Chronic Obstructive Pulmonary Disease Patients at High Mortality Risk.
  Frontiers in medicine 2018 Blagev DP, Collingridge DS, Rea S, Horne BD, Press VG, Churpek MM, Carey KA, Mularski RA, Zeng S, Arjomandi M
• Lung volumes identify an at-risk group in persons with prolonged secondhand tobacco smoke exposure but without overt airflow obstruction.
  BMJ open respiratory research 2018 Arjomandi M, Zeng S, Geerts J, Stiner RK, Bos B, van Koeverden I, Keene J, Elicker B, Blanc PD, Gold WM
• Increasing the Resolution of Chronic Obstructive Pulmonary Disease Definition. Lessons from a Cohort with Remote but Extensive Exposure to Secondhand Tobacco Smoke.
  Annals of the American Thoracic Society 2018 Arjomandi M, Zeng S, Blanc PD, Gold WM
• Diagnosing Chronic Obstructive Pulmonary Disease Among Afghanistan and Iraq Veterans: Veterans Affair's Concordance With Clinical Guidelines for Spirometry Administration.
  Military medicine 2017 Schneiderman AI, Dougherty DD, Fonseca VP, Wolters CL, Bossarte RM, Arjomandi M
• Multicenter Ozone Study in oldEr Subjects (MOSES): Part 1. Effects of Exposure to Low Concentrations of Ozone on Respiratory and Cardiovascular Outcomes.
  Research report (Health Effects Institute) 2017 Frampton MW, Balmes JR, Bromberg PA, Stark P, Arjomandi M, Hazucha MJ, Rich DQ, Hollenbeck-Pringle D, Dagincourt N, Alexis N, Ganz P, Zareba W, Costantini MG
• Modeling vascular inflammation and atherogenicity after inhalation of ambient levels of ozone: exploratory lessons from transcriptomics.
  Inhalation toxicology 2017 Tham A, Lullo D, Dalton S, Zeng S, van Koeverden I, Arjomandi M
• Asthma-COPD Overlap Syndrome- an Underdiagnosed Phenotype in Heavy Smokers.
  Journal of Allergy and Clinical Immunology 2016 Miren Guenechea-Sola, Sarah Dalton, Jeroen Geerts, Siyang Zeng, Mehrdad Arjomandi
• Inflammatory and repair pathways induced in human bronchoalveolar lavage cells with ozone inhalation.
  PloS one 2015 Leroy P, Tham A, Wong H, Tenney R, Chen C, Stiner R, Balmes JR, Paquet AC, Arjomandi M
• Exposure to medium and high ambient levels of ozone causes adverse systemic inflammatory and cardiac autonomic effects.
  American journal of physiology. Heart and circulatory physiology 2015 Arjomandi M, Wong H, Donde A, Frelinger J, Dalton S, Ching W, Power K, Balmes JR
• Ozone inhalation leads to a dose-dependent increase of cytogenetic damage in human lymphocytes.
  Environmental and molecular mutagenesis 2014 Holland N, Davé V, Venkat S, Wong H, Donde A, Balmes JR, Arjomandi M
• IQGAP1-dependent scaffold suppresses RhoA and inhibits airway smooth muscle contraction.
  The Journal of clinical investigation 2014 Bhattacharya M, Sundaram A, Kudo M, Farmer J, Ganesan P, Khalifeh-Soltani A, Arjomandi M, Atabai K, Huang X, Sheppard D
• Secondhand Tobacco Smoke and COPD Risk in Smokers: A COPDGene Study Cohort Subgroup Analysis.
  COPD 2014 van Koeverden I, Blanc PD, Bowler RP, Arjomandi M
• Hidden Costs of Climate Change: Contribution of Ozone to Human Diseases
  Proceedings of the American Association for the Advancement of Science. Proceedings of the U.S.-Iran Symposium on Air Pollution in Megacities. 2013
• Mfge8 suppresses airway hyperresponsiveness in asthma by regulating smooth muscle contraction.
  Proceedings of the National Academy of Sciences of the United States of America 2012 Kudo M, Khalifeh Soltani SM, Sakuma SA, McKleroy W, Lee TH, Woodruff PG, Lee JW, Huang K, Chen C, Arjomandi M, Huang X, Atabai K
• Oxidative Injury Due to Inhalation of Ozone Causes Dose-Dependent Cytogenetic Damage in Peripheral Blood Lymphocytes.
  Annals of the American Thoracic Society 2012 Mehrdad Arjomandi, Subha Venkat, Hofer Wong, Aneesh Donde, John Balmes, Nina Holland
• Reduced exercise tolerance and pulmonary capillary recruitment with remote secondhand smoke exposure.
  PloS one 2012 Arjomandi M, Haight T, Sadeghi N, Redberg R, Gold WM
• Effects of exercise on systemic inflammatory, coagulatory, and cardiac autonomic parameters in an inhalational exposure study.
  Journal of occupational and environmental medicine 2012 Donde A, Wong H, Frelinger J, Power K, Balmes JR, Arjomandi M
• Polymorphism in Osteopontin Gene (SPP1) Is Associated with Asthma and Related Phenotypes in a Puerto Rican Population.
  Pediatric allergy, immunology, and pulmonology 2011 Arjomandi M, Galanter JM, Choudhry S, Eng C, Hu D, Beckman K, Chapela R, Rodríguez-Santana JR, Rodríguez-Cintrón W, Ford J, Avila PC, Burchard EG
• Secreted osteopontin is highly polymerized in human airways and fragmented in asthmatic airway secretions.
  PloS one 2011 Arjomandi M, Frelinger J, Donde A, Wong H, Yellamilli A, Raymond W
• PAI-1 is an essential component of the pulmonary host response during Pseudomonas aeruginosa pneumonia in mice.
  Thorax 2011 Goolaerts A, Lafargue M, Song Y, Miyazawa B, Arjomandi M, Carlès M, Roux J, Howard M, Parks DA, Iles KE, Pittet JF
• Low prevalence of chronic beryllium disease among workers at a nuclear weapons research and development facility.
  Journal of occupational and environmental medicine 2010 Arjomandi M, Seward J, Gotway MB, Nishimura S, Fulton GP, Thundiyil J, King TE, Harber P, Balmes JR
• Pulmonary function abnormalities in never-smoking flight attendants exposed to secondhand tobacco smoke in the aircraft cabin.
  Journal of occupational and environmental medicine 2009 Arjomandi M, Haight T, Redberg R, Gold WM
• Is there an association between lifetime cumulative exposure and acute pulmonary responses to ozone?
  Journal of occupational and environmental medicine 2008 Arjomandi M, Tager IB, Bastaki M, Chen C, Holland N, Balmes JR
• Effects of chronic and acute ozone exposure on lipid peroxidation and antioxidant capacity in healthy young adults.
  Environmental health perspectives 2007 Chen C, Arjomandi M, Balmes J, Tager I, Holland N
• Effects of antioxidant enzyme polymorphisms on ozone-induced lung function changes.
  The European respiratory journal 2007 Chen C, Arjomandi M, Tager IB, Holland N, Balmes JR
• Cytogenetic damage in buccal epithelia and peripheral lymphocytes of young healthy individuals exposed to ozone.
  Mutagenesis 2006 Chen C, Arjomandi M, Qin H, Balmes J, Tager I, Holland N
• Effects of nitrogen dioxide on allergic airway responses in subjects with asthma.
  Journal of occupational and environmental medicine 2005 Witten A, Solomon C, Abbritti E, Arjomandi M, Zhai W, Kleinman M, Balmes J
• Sputum induction and bronchoscopy for assessment of ozone-induced airway inflammation in asthma.
  Chest 2005 Arjomandi M, Schmidlin I, Girling P, Boylen K, Ferrando R, Balmes J
• Repeated exposure to ozone increases alveolar macrophage recruitment into asthmatic airways.
  American journal of respiratory and critical care medicine 2005 Arjomandi M, Witten A, Abbritti E, Reintjes K, Schmidlin I, Zhai W, Solomon C, Balmes J
• Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits.
  Journal of the American College of Cardiology 1996 Wang BY, Candipan RC, Arjomandi M, Hsiun PT, Tsao PS, Cooke JP
• Effects of immunosuppressants FK506 and rapamycin on the heterooligomeric form of the progesterone receptor.
  The Journal of steroid biochemistry and molecular biology 1994 Renoir JM, Le Bihan S, Mercier-Bodard C, Gold A, Arjomandi M, Radanyi C, Baulieu EE